All authors declare that they have no competing interests.
FS conceived the study, accompanied the data acquisition, collected the data and drafted the manuscript. SJ analyzed the data and helped writing the manuscript. SM analyzed the data. TM collected the data. NR participated in the design of the study. MA participated in the design of the study, collected and analyzed the data. All authors read and approved the final manuscript.
While the impact of volatile anaesthetics to induce malignant hyperthermia (MH) is abundantly clear, the role of succinylcholine still remains controversial. To evaluate the influence of succinylcholine on porcine MH events, the authors investigated the hemodynamic and metabolic responses in MH susceptible (MHS) and non-susceptible (MHN) swine following either succinylcholine or halothane application alone or a combination of both substances.
With approval of the local animal care committee 27 MHS and 30 MHN pigs were anaesthetized and mechanically ventilated. Fiberoptic probes for continuous PCO2 measurement were inserted into the femoral vein and the triceps muscle. Group A received succinylcholine 4 mg/kg, group B incremental doses of halothane (0.5, 1.0 vol%) and group C succinylcholine and halothane simultaneously. Vital signs were recorded continuously.
Prior to drug application measured values did not differ between MHS and MHN. While MHN pigs did not show relevant alterations, succinylcholine, halothane and the combination of both lead to significant hemodynamic and metabolic changes in MHS swine.
Hemodynamic and metabolic alterations following succinylcholine were similar to halothane in MHS pigs. The combination of both pharmacological agents potentiated the observed effects. According to these results succinylcholine acted as an independent and supportive factor during onset of an MH episode.
Metterlein T, Schuster F, Kranke P, Roewer N, Anetseder M: In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?. Eur J Anaesthesiol. 2011, 28: 251-255. PubMed
Bandschapp O, Girard T: Malignant hyperthermia. Swiss Med Wkly. 2012, 31: 142-
Diaz-Sylvester PL, Porta M, Copello JA: Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP. Am J Physiol Cell Physiol. 2008, 294: 1103-1112. 10.1152/ajpcell.90642.2007. CrossRef
Klingler W, Heiderich S, Girard T, Gravino E, Heffron J, Johannsen S, Jurkat-Rott K, Rüffert H, Schuster F, Snoeck M, Sorrentino V, Tegazzin V, Lehmann-Horn F: Functional and genetic characterization of clinical malignant hyperthermia crises: a multicenter study. Orphanet J Rare Dis. 2014, 9: 8-10.1186/1750-1172-9-8. CrossRefPubMedPubMedCentral
Schuster F, Schöll H, Hager M, Müller R, Roewer N, Anetseder M: The dose–response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs. Anesth Analg. 2006, 102: 468-472. 10.1213/01.ane.0000189553.57833.11. CrossRefPubMed
Hall LW, Trim CM, Woolf N: Further studies of porcine malignant hyperthermia. Br Med J. 1972, 15: 145-148. CrossRef
Pollock AN, Langton EE, Couchman K, Stowell KW, Waddington M: Suspected malignant hyperthermia reactions in New Zealand. Anaesth Intensive Care. 2002, 30: 453-461. PubMed
Antognini JF: Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures. Anesth Analg. 1995, 81: 1038-1042.
- The effect of succinylcholine on malignant hyperthermia events in susceptible swine
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II